z-logo
open-access-imgOpen Access
Combination of TNF-a, Homocysteine and Adenosine Exacerbated Cytotoxicity in Human Cardiovascular and Cerebrovascular Endothelial Cells
Author(s) -
Antony Kam,
Kong M. Li,
Valentina RazmovskiNaumovski,
Srinivas Nammi,
Kelvin Chan,
George Li
Publication year - 2012
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000341459
Subject(s) - adenosine , apoptosis , tumor necrosis factor alpha , poly adp ribose polymerase , programmed cell death , homocysteine , dna fragmentation , endothelial dysfunction , endothelium , endothelial stem cell , phosphatidylserine , pharmacology , cancer research , medicine , microbiology and biotechnology , endocrinology , biology , biochemistry , phospholipid , polymerase , enzyme , in vitro , membrane
Disruption to the vascular homoeostasis is detrimental in vascular diseases. This study examined how the combination of homocysteine, adenosine and tumor necrosis factor-alpha (TNF-α) influenced endothelial cell survival. In cultured human-derived cardiovascular (EA.hy926) and cerebrovascular (HBEC-5i) endothelial cells, cell death events were initiated by TNF-α (0.1-10 ng/mL) only when both homocysteine (0.5 mM) and adenosine (0.5 mM) were present. The accelerated cell death events induced by the combination were triggered through excessive apoptosis. This was evident by membrane phospholipid phosphatidylserine externalisation, cell shrinkage and DNA fragmentation, as well as an increase in the expressions and occurrence of active caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) positive cells. Collectively, homocysteine, adenosine and TNF-α are interrelated in the survival of endothelial cells, and this co-existence should be considered in future drug development for cardiovascular and cerebrovascular diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom